Advertisement

Topics

ICON plc Company Profile

09:55 EDT 20th March 2019 | BioPortfolio

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently employs over 7,300 employees, operating from 71 locations in 39 countries.


News Articles [53 Associated News Articles listed on BioPortfolio]

ICON Acquires MolecularMD

Deal brings to ICON expanded testing platforms, including next generation sequencing, and immunohistochemistry (IHC)

ICON Acquires Precision Medicine for Oncology Company MolecularMD

ICON, a global provider of drug development solutions and services has acquired MolecularMD, a molecular diagnostic specialty laboratory that enables the development and commercialization of precision...

ICON buys US molecular diagnostics lab

MolecularMD, a molecular diagnostics lab based in Portland, Ore., was acquired by ICON for an undisclosed amount.  -More- 

Icon introduces new drug safety reporting solution

Iconâs new drug safety reporting platform automates complex processes to ensure compliance in the âever-changingâ regulatory environment, says VP.

R B and Pop Icon Valerie Simpson and Pulitzer Prize-Winning Composer Melinda Wagner Receive Top ...

NEW YORK, Dec. 12, 2018 /PRNewswire/ -- The ASCAP Foundation honored R&B and pop icon Valerie Simpson with its George M. Cohan Friars Foundation Award Read more...

Icon launches technology for adaptive clinical trial design

Icon has launched an integrated technology platform for the design, simulation, and analysis of adaptive clinical trials.

ICON CEO: CROs Must Be Aware Of Threat Posed By Big Tech

ICON’s CEO Steve Cutler talks candidly about the impact of biotech funding, disruptive tech providers, and the constant pressure of...   

Icon reports record awards in Q3, outlines 3-part patient recruitment strategy

Icon reported a record number of new business awards in Q3 and outlined its three-part patient recruitment strategy as well as global hiring â and acquiring â plans.

Drugs and Medications [22 Associated Drugs and Medications listed on BioPortfolio]

Tetracaine hydrochloride [bausch & lomb incorporated]

Tetracaine Hydrochloride Ophthalmic Solution USP, 0.5% (Sterile) Rx only

Tetracaine hydrochloride [amici pharmaceuticals llc]

Tetracaine Hydrochloride Ophthalmic Solution USP, 0.5% (Sterile) Rx only

Tetracaine hydrochloride [preferred pharmaceuticals, inc.]

Tetracaine Hydrochloride Ophthalmic Solution USP, 0.5% (Sterile) Rx only

Gentamicin sulfate [proficient rx lp]

Gentamicin Sulfate Ophthalmic Solution USP, 0.3% (Sterile)

Erythromycin [proficient rx lp]

Erythromycin Ophthalmic Ointment USP, 0.5% (Sterile)

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

Non-invasive proximal adhesive restoration (NIPAR) compared to resin infiltration for treating initial proximal carious lesions.

To compare a new technique of non-invasive proximal adhesive restoration (NIPAR) to the infiltration concept technique (ICON).

Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.

To define predictors for the 2-year outcome in terms of achieving inactivity, subsequent uveitis reactivation and occurrence of uveitis-related complications of JIA-associated uveitis.

Simultaneous optimization of isocenter locations and sector duration in radiosurgery.

Stereotactic radiosurgery is an effective technique to treat brain tumors for which several inverse planning methods may be appropriate. We propose an integer programming model to simultaneous sector ...

Implementation and assessment of the black body bias correction in quantitative neutron imaging.

We describe in this paper the experimental procedure, the data treatment and the quantification of the black body correction: an experimental approach to compensate for scattering and systematic biase...

Population pharmacokinetic analysis of bisoprolol in patients with acute coronary syndrome.

To date, many questions about the extent and cause of pharmacokinetic variability of even the most widely studied and prescribed β1-adrenergic receptor blockers, such as metoprolol and bisoprolol, re...

Clinical Trials [15 Associated Clinical Trials listed on BioPortfolio]

The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances

The aim of this study is to determine the effect of ICON on White spot lesions compared to CPP-ACPF plus.

Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to evaluate the safety and effects of repeated intravitreal injections of ICON-1 0.6 mg administered as maintenance therapy or in combination with aflibercept ...

Randomized Controlled Crossover Comparison of Icon Underwear to Disposable Pads

This is a randomized cross over trial to compare quality of life and product performance between Icon reusable underwear versus standard disposable pad in patients with mild to moderate ur...

Non-invasive Monitor in Endoscopic Invasive Procedure

We include the patients who need painless invasive endoscopic precedure, we collect the dempgraphic data and apply the non-invasive device ICON on patients during the who procedure.

Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation

The aim of the study is to investigate the use of a new FDA-approved non-invasive bio-impedance cardiac monitor, ICON, to detect hemodynamic effects during sedation in children undergoing ...

Companies [28 Associated Companies listed on BioPortfolio]

ICON Clinical Research

ICON was founded in 1990 by a group of experienced professionals, who were dedicated to providing the pharmaceutical and biotechnology industries with exceptional clinical research and biometric servi...

ICON Eyecare

ICON Eyecare is a leading surgical and medical eye care provider, based out of Denver, CO. Since 1999, ICON has been building a Center of Ophthalmology Excellence empowered by an ...

ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic devel...

ICON plc.

ICON plc. is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic deve...

ALTRA Footwear

ALTRA is exhibiting at the Outdoor Retailer 2011 Summer Market in Booth number 38160. ALTRA Footwear was founded in 2009 and acquired in March 2011 by ICON Health & Fitness, the l...

More Information about "ICON plc" on BioPortfolio

We have published hundreds of ICON plc news stories on BioPortfolio along with dozens of ICON plc Clinical Trials and PubMed Articles about ICON plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ICON plc Companies in our database. You can also find out about relevant ICON plc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record